Cargando…
BIRC5 is a prognostic biomarker associated with tumor immune cell infiltration
BIRC5 is an immune-related gene that inhibits apoptosis and promotes cell proliferation. It is highly expressed in most tumors and leads to poor prognosis in cancer patients. This study aimed to analyze the relationship between the expression level of BIRC5 in different tumors and patient prognosis,...
Autores principales: | Xu, Linlong, Yu, Wenpeng, Xiao, Han, Lin, Kang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801710/ https://www.ncbi.nlm.nih.gov/pubmed/33431968 http://dx.doi.org/10.1038/s41598-020-79736-7 |
Ejemplares similares
-
The N6-Methylandenosine-Related Gene BIRC5 as a Prognostic Biomarker Correlated With Cell Migration and Immune Cell Infiltrates in Low Grade Glioma
por: Jiang, Xiulin, et al.
Publicado: (2022) -
BIRC5 Modulates PD-L1 Expression and Immune Infiltration in Lung Adenocarcinoma
por: Ma, Teng, et al.
Publicado: (2022) -
Pan-cancer analysis identifies BIRC5 as a prognostic biomarker
por: Fäldt Beding, Anna, et al.
Publicado: (2022) -
BIRC3 and BIRC5: multi‐faceted inhibitors in cancer
por: Frazzi, Raffaele
Publicado: (2021) -
ITGA5 is a prognostic biomarker and correlated with immune infiltration in gastrointestinal tumors
por: Zhu, Hai, et al.
Publicado: (2021)